vs
Side-by-side financial comparison of Piedmont Realty Trust, Inc. (PDM) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
USANA HEALTH SCIENCES INC is the larger business by last-quarter revenue ($250.2M vs $143.3M, roughly 1.7× Piedmont Realty Trust, Inc.). USANA HEALTH SCIENCES INC runs the higher net margin — 3.0% vs -31.4%, a 34.4% gap on every dollar of revenue. On growth, Piedmont Realty Trust, Inc. posted the faster year-over-year revenue change (0.4% vs -3.0%). Over the past eight quarters, USANA HEALTH SCIENCES INC's revenue compounded faster (11.8% CAGR vs 0.0%).
Piedmont Realty Trust, Inc. is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality office properties primarily located in high-growth metropolitan areas across the United States. It serves corporate tenants across multiple industry sectors including technology, professional services, and healthcare, and pursues stable long-term returns for stakeholders via strategic property management and portfolio optimization.
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
PDM vs USNA — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2027
| Metric | | |
|---|---|---|
| Revenue | $143.3M | $250.2M |
| Net Profit | $-45.0M | $7.5M |
| Gross Margin | — | 76.2% |
| Operating Margin | — | 5.5% |
| Net Margin | -31.4% | 3.0% |
| Revenue YoY | 0.4% | -3.0% |
| Net Profit YoY | -27.9% | -20.0% |
| EPS (diluted) | $-0.10 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $143.3M | $250.2M | ||
| Q4 25 | $142.9M | $226.2M | ||
| Q3 25 | $139.2M | $213.7M | ||
| Q2 25 | $140.3M | $235.8M | ||
| Q1 25 | $142.7M | $249.5M | ||
| Q4 24 | $143.2M | $213.6M | ||
| Q3 24 | $139.3M | $200.2M | ||
| Q2 24 | $143.3M | — |
| Q1 26 | $-45.0M | $7.5M | ||
| Q4 25 | $-43.2M | $180.0K | ||
| Q3 25 | $-13.5M | $-6.5M | ||
| Q2 25 | $-16.8M | $9.7M | ||
| Q1 25 | $-10.1M | $9.4M | ||
| Q4 24 | $-30.0M | $4.5M | ||
| Q3 24 | $-11.5M | $10.6M | ||
| Q2 24 | $-9.8M | — |
| Q1 26 | — | 76.2% | ||
| Q4 25 | — | 78.2% | ||
| Q3 25 | — | 77.2% | ||
| Q2 25 | — | 78.7% | ||
| Q1 25 | — | 79.0% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | — | 80.4% | ||
| Q2 24 | — | — |
| Q1 26 | — | 5.5% | ||
| Q4 25 | — | 1.7% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 7.1% | ||
| Q1 25 | — | 6.3% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | — | — |
| Q1 26 | -31.4% | 3.0% | ||
| Q4 25 | -30.3% | 0.1% | ||
| Q3 25 | -9.7% | -3.1% | ||
| Q2 25 | -12.0% | 4.1% | ||
| Q1 25 | -7.1% | 3.8% | ||
| Q4 24 | -20.9% | 2.1% | ||
| Q3 24 | -8.3% | 5.3% | ||
| Q2 24 | -6.8% | — |
| Q1 26 | $-0.10 | $0.41 | ||
| Q4 25 | $-0.34 | $-0.10 | ||
| Q3 25 | $-0.11 | $-0.36 | ||
| Q2 25 | $-0.14 | $0.52 | ||
| Q1 25 | $-0.08 | $0.49 | ||
| Q4 24 | $-0.25 | $0.23 | ||
| Q3 24 | $-0.09 | $0.56 | ||
| Q2 24 | $-0.08 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.3M | $162.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.5B | — |
| Total Assets | $4.0B | $739.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $2.3M | $162.8M | ||
| Q4 25 | $731.0K | $158.4M | ||
| Q3 25 | $3.0M | $145.3M | ||
| Q2 25 | $3.3M | $151.3M | ||
| Q1 25 | $2.9M | $179.6M | ||
| Q4 24 | $109.6M | $181.8M | ||
| Q3 24 | $133.6M | $364.9M | ||
| Q2 24 | $138.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $2.2B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.2B | — | ||
| Q3 24 | $2.2B | — | ||
| Q2 24 | $2.2B | — |
| Q1 26 | $1.5B | — | ||
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | $528.1M | ||
| Q2 25 | $1.5B | $531.1M | ||
| Q1 25 | $1.6B | $529.8M | ||
| Q4 24 | $1.6B | $532.1M | ||
| Q3 24 | $1.6B | $533.1M | ||
| Q2 24 | $1.7B | — |
| Q1 26 | $4.0B | $739.0M | ||
| Q4 25 | $4.0B | $742.9M | ||
| Q3 25 | $4.0B | $726.6M | ||
| Q2 25 | $4.0B | $734.5M | ||
| Q1 25 | $4.0B | $746.6M | ||
| Q4 24 | $4.1B | $748.2M | ||
| Q3 24 | $4.1B | $671.3M | ||
| Q2 24 | $4.2B | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.49× | — | ||
| Q3 25 | 1.43× | — | ||
| Q2 25 | 1.41× | — | ||
| Q1 25 | 1.40× | — | ||
| Q4 24 | 1.40× | — | ||
| Q3 24 | 1.36× | — | ||
| Q2 24 | 1.34× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
